Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 9/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404277 | 1.00 | MEN1 (0.51) | MEN1KMT2AASAH1CTSKCTSS | |
| SCHEMBL1479708 | 0.83 | MEN1 (0.59) | MEN1KMT2AASAH1CYP2D6TP53 | |
| SCHEMBL29436230 | 0.83 | MEN1 (0.59) | MEN1KMT2AASAH1CYP2D6TP53 | |
| SCHEMBL1479154 | 0.83 | MEN1 (0.59) | MEN1KMT2AASAH1CYP2D6TP53 | |
| SCHEMBL15685427 | 0.82 | MEN1 (0.52) | MEN1KMT2AASAH1CYP2D6TP53 | |
| SCHEMBL30905694 | 0.82 | CTSK (0.39) | MEN1KMT2AASAH1CTSKCTSS | |
| SCHEMBL17522133 | 0.81 | PLA2G4A (0.46) | MEN1KMT2ACTSKCTSSCA1 | |
| SCHEMBL5276500 | 0.80 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL5269469 | 0.80 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL5268067 | 0.80 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109689063-B | Alkyne-containing nucleotide and nucleoside therapeutic compositions and related uses thereof | 埃默里大学 | 2026-02-27 | — | — | CN | disclosed |
| CN-119633010-A | 4' -Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses | 埃默里大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-112074506-B | 4' -Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses | 埃默里大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-118477090-A | 4' -Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses | 埃默里大学 | 2024-08-13 | — | — | CN | disclosed |
| CN-114867351-B | 4' -Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses | 埃默里大学 | 2024-04-23 | — | — | CN | disclosed |
| CN-117881402-A | Nucleotide and nucleoside therapeutic compositions, combinations, and uses related thereto | 埃默里大学 | 2024-04-12 | — | — | CN | disclosed |
| US-6852892-B2 | Process for the synthesis of sphingosine | GOLDSCHMIDT AG (DE) | 2005-02-08 | — | — | US | disclosed |
| EP-1452520-A1 | A process for the synthesis of sphingosine | Cosmoferm B.V. (NL) | 2004-09-01 | — | — | EP | disclosed |
| US-20030171621-A1 | Process for the synthesis of sphingosine | EVONIK INDUSTRIES AG (DE) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171621-A1 | Process for the synthesis of sphingosine | S1PR4, S1PR3, S1PR2 | MEN1 707/4885KMT2A 2872/4885ASAH1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.